Cellares and University of Wisconsin Agree to Automate Clinical-Scale Production of CRISPR-Edited CAR-T

Cellares and University of Wisconsin School of Medicine and Public Health to Automate Clinical-Scale Production of CRISPR-Edited CAR-T for Solid Tumors

SAN FRANCISCO & MADISON, Wis.--(BUSINESS WIRE)--Apr 10, 2025-

A research team from Helmholtz Munich and the Technical University of Munich has developed an advanced delivery system for molecular gene-editing tools such as the CRISPR/Cas9 system. This now enables significantly greater efficiency in introducing them into living cells...

Cellares and University of Wisconsin Agree to Automate Clinical-Scale Production of CRISPR-Edited CAR-T

Cellares agreed to collaborate with the University of Wisconsin School of Medicine and Public Health to automate the manufacturing of a CRISPR-edited GD2 CAR-T investigational therapy. Company officials say their Cell ShuttleTM supports early-phase biotechnology and academic cell therapy developers by providing an integrated, automated solution enabling economies of scale. The platform ensures a seamless transition from clinical development to c…

Cellares and UW-Madison partner to automate CAR-T manufacturing

Cell therapies hold immense promise but, traditionally, carry a similarly large price tag often linked to complex, manual manufacturing. In its latest move to help make these life-saving  and -enhancing treatments more scalable and potentially accessible, Cellares is partnering with the University of Wisconsin School of Medicine and Public Health to automate the clinical-scale manufacturing… The post Cellares and UW-Madison partner to automate m…